Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05753163
What this trial is testing

Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study

Who this might be right for
Colorectal Liver Metastasis
Fudan University 44
Large-scale testing (Phase 3)Looking for participantsNCT05863195
What this trial is testing

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8+1 more
ECOG-ACRIN Cancer Research Group 408
Large-scale testing (Phase 3)UnknownNCT03775395
What this trial is testing

HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 250
Testing effectiveness (Phase 2)UnknownNCT06293287
What this trial is testing

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

Who this might be right for
Radial Artery Occlusion
Zhongshan Hospital (Xiamen), Fudan University 156
Testing effectiveness (Phase 2)Temporarily pausedNCT01233102
What this trial is testing

Mesenchymal Stem Cells Treat Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Yufang Shi 200
Testing effectiveness (Phase 2)Looking for participantsNCT07776080
What this trial is testing

Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
HCC - Hepatocellular Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 35
Not applicableUnknownNCT05573282
What this trial is testing

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 50
Large-scale testing (Phase 3)Looking for participantsNCT06041477
What this trial is testing

Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC

Who this might be right for
Hepatocellular CarcinomaChemotherapy EffectChemotherapeutic Toxicity
Sun Yat-sen University 540
Testing effectiveness (Phase 2)UnknownNCT00356161
What this trial is testing

HAI Via Interventionally Implanted Port Catheter Systems

Who this might be right for
Colorectal CancerLiver NeoplasmsHepatocellular Carcinoma+2 more
Charite University, Berlin, Germany 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06389500
What this trial is testing

HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Harbin Medical University 30
Not applicableLooking for participantsNCT06333561
What this trial is testing

HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLenvatinibPD-1 Inhibitor+1 more
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492999
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 64
Testing effectiveness (Phase 2)Looking for participantsNCT07284836
What this trial is testing

Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy

Who this might be right for
Hepatic Artery InfusionLiver Metastasis of Breast Cancer
Zhejiang Cancer Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Not applicableStudy completedNCT06199232
What this trial is testing

Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

Who this might be right for
Liver Metastasis Colon CancerctDNA GenotypeMSS+1 more
Peking University 47
Not applicableLooking for participantsNCT06519578
What this trial is testing

Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
RenJi Hospital 1,115
Early research (Phase 1)Looking for participantsNCT07021534
What this trial is testing

Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial

Who this might be right for
Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments
Zhejiang University 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06375317
What this trial is testing

HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure

Who this might be right for
HCC - Hepatocellular Carcinoma
Yehua Shen 42
Testing effectiveness (Phase 2)UnknownNCT06375486
What this trial is testing

Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Study completedNCT00008294
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Next Page